Curemark logo

Curemark

A biopharmaceutical company that develops therapies to treat Autism, neurological and other disorders

2

Funding Rounds

$25.0m

Money raised

Overview

A biopharmaceutical company that develops therapies to treat Autism, neurological and other disorders

Funding

Funding series

Funding Series Analysis

The company Curemark has raised a total of $25m in funding over 2 rounds.

Key Insights:

  • Curemark funding round, October 2013: $18.5m
  • Curemark Series A round: $6.5m
Curemark logo
Curemark funding round, October 2013 $18.5m
Curemark logo
Curemark Series A round $6.5m